About
Omar Consulting Group-Global and its partners provide educational, scientific and clinical R&D leadership and services for global biotech and pharma clients seeking to understand US regulatory and/or expand clinical trials to North America.
The value we provide
- Integrate with your existing teams
- Provide information and subject matter expertise
- Solve problems and create strategies
- Assist with implementation of recommended solutions
- Provide leadership and representation with regulatory agencies
- Operationalize clinical trials
- Build consensus and commitment
- Facilitate client learning
- Improve your value proposition
Global
Omar Consulting Group-Global and its partners provide educational, scientific and clinical R&D leadership and services for global biotech and pharma clients seeking to understand US regulatory and/or expand clinical trials to North America.
US

Founded in 2005, Omar Consulting Group-US focuses on forging and managing long-term productive relations with business alliance teams, industry stakehoders, scientists and physicians in biotect and pharma to create pathways for the development and commercialization of new medical therapies.
Ex-US

China:
Traditional medicines and novel approaches to: cancer, irritable bowel disease, diabetic retinopathy, macular degeneration, and pain review of documents SFDA, and execution of clinical trials in North America.

European Union:
Novel drug therapies and devices, ICH compliant studies and operations, protocol development and de-risking.

UK:
Rare diseases of the retina; novel gene delivery methods.

Japan:
Japanese bridging studies, clinical development plans, regulatory strategies.